Karyopharm Therapeutics (KPTI) PT Raised to $18 at Wedbush
Tweet Send to a Friend
Wedbush raised its price target on Karyopharm Therapeutics (NASDAQ: KPTI) to $18.00 (from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
